Aberrant HLA-G expression has been observed in lung cancer tissue [9–11] and relatively high blood soluble HLA-G (sHLA-G) levels have been associated with lung cancer and advanced clinical disease stages [12–14]. This evidence concerns the gene HLA-G and lung carcinoma.